Insmed Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

47.21%

Market Cap

19.30 Bil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-5.69 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE89.33 G0 Units
PRICE DETERMINATION TIME06/03/2026 / 09:57:03 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW89.7787.77
PREV. DAY'S PRICE89.06 (06/02)
CHANGE DAY BEFORE
+0.27
0.30 %
52 WEEK HIGH / LOW184 (11/26)61.5 (06/10)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE0.50-2.26-5.69-5.15-4.94
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO183.93----
PRICE - BOOK RATIO--50.4643.40-
PRICE - SALES RATIO--57.1231.1414.26
PRICE - CASH FLOW RATIO-----
Further Key Figures

Master Data

WKN
A1JJA3
ISIN
US4576693075
SYMBOL
IM8N
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Insmed
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
216.75 Mil.
MARKET CAPITALISATION
19.30 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.84 %
-23.30 %
-28.75 %
-49.97 %
47.21 %
397.54 %
328.17 %
-39.82 %
HIGH93.99120.80142.00177.00184.00184.00184.00154.00
LOW86.7584.2484.2484.2461.5017.6014.8084.24
Dividend
per share
Insmed does not deliver dividend information

Company profile

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.